Learn about how different healthcare providers work together to help breast cancer patients weigh their treatment options.

In a study co-led by the University of Maryland School of Medicine (UMSOM), researchers have identified a "master regulator" ...

C, provided insights on what to consider when treating patients with HR+, HER2- breast cancer in the second line of treatment.

During a live event, Payal D. Shah, MD, discusses the case of a woman with metastatic breast cancer and the data for ...

Jim Willwerth, in this horticulture discussion, delves into hormonal therapy for grapevines, including plant growth ...

HealthDay News — Some commonly prescribed photosensitizing drugs increase skin cancer risk, according to a study published online March 18 in Photodermatology, Photoimmunology & Photomedicine.

Most women with breast cancer who paused endocrine therapy to get pregnant did not restart treatment after having a child, ...

The company is expanding its cardiology portfolio with a new treatment for transthyretin amyloid cardiomyopathy in Europe.

A new drug tested in a phase 3 trial showed significant improvement in patients with treatment-resistant ovarian cancer.

Research from Weill Cornell Medicine has identified a molecular pathway linking omega-6 linoleic acid—a common dietary fat in ...

A team has developed a new way to quickly find personalized treatments for young cancer patients, by growing their tumors in chicken eggs and analyzing their proteins. The team has combined these two ...

Discover what every stage of breast cancer means for treatment options and recovery, with expert insights to help navigate a ...